Clinical Trial Update: Vanguard Study for Head and Neck Cancer or Non-Small Cell Lung Cancer (NSCLC) Patients

View source ↗

Summary

The Vanguard Study for head and neck cancer and non-small cell lung cancer has completed enrollment and the document provides a status update. No detailed resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Non-small Cell Lung Cancer

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Head and Neck Cancer, Lung Cancer | Status: COMPLETED